Interferon-γ upregulates the c-Met/hepatocyte growth factor receptor expression in alveolar epithelial cells

被引:27
作者
Nagahori, T
Dohi, M
Matsumoto, K
Saitoh, K
Honda, ZI
Nakamura, T
Yamamoto, K
机构
[1] Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Bunkyo Ku, Tokyo 1138655, Japan
[2] Osaka Univ, Sch Med, Biomed Res Ctr, Div Biochem, Osaka 553, Japan
关键词
D O I
10.1165/ajrcmb.21.4.3614
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In the repair process after lung injury, the regeneration of alveolar epithelial cells plays an important role by covering the damaged alveolar wall and preventing the activated fibroblasts from invading the intraalveolar spaces. Hepatocyte growth factor (HGF) is a potent mitogen for alveolar epithelial cells and has been reported to be capable of repressing the fibrosing process by connecting to the c-Met/HGF receptor on alveolar epithelial cells. However, it has been reported that the c-Met expression was downregulated in an acute phase of lung injury, which may limit the effect of HGF for therapeutic use. In the present study we observed that interferon (IFN)-gamma upregulates the c-Met messenger RNA (mRNA) and protein expression in A549 alveolar epithelial cells. We analyzed the mechanism of this upregulation and found that IFN-gamma enhances the transcription of the c-met proto-oncogene, and that it does not prolong the stability of the c-Met mRNA. HGF is known to act as a mitogen as well as a mitogen for epithelial cells. We also found that the migratory activity of A549 cells induced by HGF is strongly enhanced by preincubation with IFN-gamma. Finally, we administered recombinant IFN-gamma to C57BL/6 mice and confirmed that this upregulation is also observed in vivo. These results suggest that the combination of HGF and IFN-gamma could be a new therapeutic approach for fibrosing pulmonary diseases.
引用
收藏
页码:490 / 497
页数:8
相关论文
共 56 条
[1]  
ADAMSON IYR, 1988, AM J PATHOL, V130, P377
[2]   DIFFERENTIAL TUBULOGENIC AND BRANCHING MORPHOGENETIC ACTIVITIES OF GROWTH-FACTORS - IMPLICATIONS FOR EPITHELIAL TISSUE-DEVELOPMENT [J].
BARROS, EJG ;
SANTOS, OFP ;
MATSUMOTO, K ;
NAKAMURA, T ;
NIGAM, SK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (10) :4412-4416
[3]   MODULATION OF ALVEOLAR MACROPHAGE DRIVEN FIBROBLAST PROLIFERATION BY ALTERNATIVE MACROPHAGE MEDIATORS [J].
BITTERMAN, PB ;
WEWERS, MD ;
RENNARD, SI ;
ADELBERG, S ;
CRYSTAL, RG .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 77 (03) :700-708
[4]   IDENTIFICATION OF THE HEPATOCYTE GROWTH-FACTOR RECEPTOR AS THE C-MET PROTOONCOGENE PRODUCT [J].
BOTTARO, DP ;
RUBIN, JS ;
FALETTO, DL ;
CHAN, AML ;
KMIECIK, TE ;
VANDEWOUDE, GF ;
AARONSON, SA .
SCIENCE, 1991, 251 (4995) :802-804
[5]   ELEVATED IL-8 AND MCP-1 IN THE BRONCHOALVEOLAR LAVAGE FLUID OF PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS AND PULMONARY SARCOIDOSIS [J].
CAR, BD ;
MELONI, F ;
LUISETTI, M ;
SEMENZATO, G ;
GIALDRONIGRASSI, G ;
WALZ, A .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 149 (03) :655-659
[6]  
CHAN AML, 1988, ONCOGENE, V2, P593
[7]  
CHEN YP, 1994, J BIOL CHEM, V269, P18307
[8]   MOLECULAR-CLONING OF A NEW TRANSFORMING GENE FROM A CHEMICALLY TRANSFORMED HUMAN CELL-LINE [J].
COOPER, CS ;
PARK, M ;
BLAIR, DG ;
TAINSKY, MA ;
HUEBNER, K ;
CROCE, CM ;
VANDEWOUDE, GF .
NATURE, 1984, 311 (5981) :29-33
[9]  
CROUCH E, 1990, AM J PHYSIOL, V259, P159
[10]   IDIOPATHIC PULMONARY FIBROSIS - CLINICAL, HISTOLOGIC, RADIOGRAPHIC, PHYSIOLOGIC, SCINTIGRAPHIC, CYTOLOGIC, AND BIOCHEMICAL ASPECTS [J].
CRYSTAL, RG ;
FULMER, JD ;
ROBERTS, WC ;
MOSS, ML ;
LINE, BR ;
REYNOLDS, HY .
ANNALS OF INTERNAL MEDICINE, 1976, 85 (06) :769-788